ArticleTranslational cancer research2020

The efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic drugs in renal cell carcinomas: a systematic review and meta-analysis.

Qian He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.